Skip to main content
Premium Trial:

Request an Annual Quote

Canon Medical Systems Acquires Majority Stake in Cancer Genomic Profiling JV

NEW YORK (GenomeWeb) — Canon Medical Systems has completed its acquisition of a majority stake in ACTmed, a Japanese joint venture established with Taiwanese molecular diagnostics firm ACT Genomics (ACTG), ACTG said today.

As part of the transaction, ACTG will transfer its clinical next-generation sequencing technology — which includes its flagship ACTOnco+ assay for determining the mutational status of solid tumors and guiding treatment selection — to ACTmed. ACTG has also agreed to support ACTmed's cancer genomic profiling operations in Japan and provide it with sequencing data analysis services.

Additional details were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.